Pulmonary consolidation

WIMI Hologram Academy: The Application of Virtual Reality technology in pulmonary function rehabilitation in COVID-19 patients

Retrieved on: 
Tuesday, September 27, 2022
Cloud, Hospital, MEP, Software, Parallel Walk Test, Pulmonary consolidation, Gastrointestinal tract, Infection, MIP, COVID-19, Time-invariant system, PCS, Pulmonary fibrosis, Immersion, Risk, Blood, Coronavirus diseases, Telehealth, Survivor, WIMI, Health, Pressure, Compliance, Partnership, Environment, Syndrome, Patient, Attention, Degenerative disease, Technology, Quality of life, Convalescence, Science, NASDAQ, Lung, Heart, Research, COPD, Rehabilitation, Virtual reality, Motivation, GLOBE, Fatigue, HIV disease progression rates, Kidney, VR, Telerehabilitation, Computer simulation, AI, HMD, Breathe Me, Coronavirus

Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc.(NASDAQ: WIMI), have been studying the Application of Virtual Reality technology in pulmonary function rehabilitation in COVID-19 patients.

Key Points: 
  • Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc.(NASDAQ: WIMI), have been studying the Application of Virtual Reality technology in pulmonary function rehabilitation in COVID-19 patients.
  • The investigators performed pulmonary rehabilitation training on 55 patients requiring pulmonary rehabilitation and with better compliance.
  • Patients were divided into two groups, the control group adopted traditional pulmonary rehabilitation strategies according to the "4S" rehabilitation principle, and the other group adopted telemedicine to manage the pulmonary rehabilitation of patients.
  • There are four types of virtual reality: immersive virtual reality, desktop virtual reality, also known as non-immersive augmented virtual reality, and simulated virtual reality.

FogChain Announces Definitive Agreement for the Acquisition of Avisa Pharma Inc.

Retrieved on: 
Tuesday, February 2, 2021
Medicine, Avisa, Pulmonary consolidation, Pneumonia, Health sciences, Health

Avisa has developed a quantitative, pointofcare diagnostic breath test known as the Avisa BreathTest ("ABT") for rapidly detecting bacterial pneumonia and pulmonary infections in approximately 10 minutes.

Key Points: 
  • Avisa has developed a quantitative, pointofcare diagnostic breath test known as the Avisa BreathTest ("ABT") for rapidly detecting bacterial pneumonia and pulmonary infections in approximately 10 minutes.
  • The FogChain Shares to be issued to Avisa in connection with the Transaction will be issued on a post-Consolidation basis.
  • Mr. Joseph has been the cofounder and CEO of five companies (including Avisa) in medical technology, biomaterials and biopharmaceuticals.
  • Disclosure of certain financial information concerning Avisa and the Resulting Issuer will be available in the disclosure document prepared by FogChain and Avisa in connection with the Transaction.

FDA permits use of icometrix's AI-based quantification for chest CT in COVID-19

Retrieved on: 
Tuesday, May 12, 2020
Medicine, Radiologic signs, Health, Clinical medicine, Medical imaging, Ground-glass opacity, Fleischner Society, Triage, Lung cancer, Radiology, Pulmonary consolidation

The AI algorithm, icolung, quantifies the degree of lung involvement in COVID-19 patients on CT in different lung regions and per type of CT findings (Ground Glass Opacity, Consolidation, and Crazy Paving Pattern).

Key Points: 
  • The AI algorithm, icolung, quantifies the degree of lung involvement in COVID-19 patients on CT in different lung regions and per type of CT findings (Ground Glass Opacity, Consolidation, and Crazy Paving Pattern).
  • Quantification can help radiologists to assess the pulmonary status, as recommended by the Fleischner Society Consensus Statement.
  • Automated quantification introduces consistency and objectivity in the assessment of regional lung pathology and can assist with the risk-based triage of COVID-19 patients with moderate to severe symptoms.
  • "We have been using icolung in clinical practice since its CE-marking and have seen that quantitative CT data is important in the triage of patients.